BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 32627027)

  • 21. P21 activated kinase-1 mediates transforming growth factor β1-induced prostate cancer cell epithelial to mesenchymal transition.
    Al-Azayzih A; Gao F; Somanath PR
    Biochim Biophys Acta; 2015 May; 1853(5):1229-39. PubMed ID: 25746720
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of S-Adenosylmethionine-Dependent Methyltransferase Attenuates TGFβ1-Induced EMT and Metastasis in Pancreatic Cancer: Putative Roles of miR-663a and miR-4787-5p.
    Mody HR; Hung SW; AlSaggar M; Griffin J; Govindarajan R
    Mol Cancer Res; 2016 Nov; 14(11):1124-1135. PubMed ID: 27624777
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
    Dong F; Liu T; Jin H; Wang W
    Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Emodin inhibits pancreatic cancer EMT and invasion by up‑regulating microRNA‑1271.
    Li N; Wang C; Zhang P; You S
    Mol Med Rep; 2018 Sep; 18(3):3366-3374. PubMed ID: 30066876
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Girdin interaction with vimentin induces EMT and promotes the growth and metastasis of pancreatic ductal adenocarcinoma.
    Wang W; Chen H; Gao W; Wang S; Wu K; Lu C; Luo X; Li L; Yu C
    Oncol Rep; 2020 Aug; 44(2):637-649. PubMed ID: 32467989
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Metformin reverses mesenchymal phenotype of primary breast cancer cells through STAT3/NF-κB pathways.
    Esparza-López J; Alvarado-Muñoz JF; Escobar-Arriaga E; Ulloa-Aguirre A; de Jesús Ibarra-Sánchez M
    BMC Cancer; 2019 Jul; 19(1):728. PubMed ID: 31337349
    [TBL] [Abstract][Full Text] [Related]  

  • 27. CK2 inhibitor CX-4945 blocks TGF-β1-induced epithelial-to-mesenchymal transition in A549 human lung adenocarcinoma cells.
    Kim J; Hwan Kim S
    PLoS One; 2013; 8(9):e74342. PubMed ID: 24023938
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigallocatechin gallate (EGCG) suppresses epithelial-Mesenchymal transition (EMT) and invasion in anaplastic thyroid carcinoma cells through blocking of TGF-β1/Smad signaling pathways.
    Li T; Zhao N; Lu J; Zhu Q; Liu X; Hao F; Jiao X
    Bioengineered; 2019 Dec; 10(1):282-291. PubMed ID: 31311401
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Astragaloside IV inhibits TGF-β1-induced epithelial-mesenchymal transition through inhibition of the PI3K/Akt/NF-κB pathway in gastric cancer cells.
    Zhu J; Wen K
    Phytother Res; 2018 Jul; 32(7):1289-1296. PubMed ID: 29480652
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Curcumin inhibits pancreatic cancer cell invasion and EMT by interfering with tumor‑stromal crosstalk under hypoxic conditions via the IL‑6/ERK/NF‑κB axis.
    Li W; Sun L; Lei J; Wu Z; Ma Q; Wang Z
    Oncol Rep; 2020 Jul; 44(1):382-392. PubMed ID: 32377752
    [TBL] [Abstract][Full Text] [Related]  

  • 31. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
    Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
    Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metformin sensitizes sorafenib to inhibit postoperative recurrence and metastasis of hepatocellular carcinoma in orthotopic mouse models.
    You A; Cao M; Guo Z; Zuo B; Gao J; Zhou H; Li H; Cui Y; Fang F; Zhang W; Song T; Li Q; Zhu X; Yin H; Sun H; Zhang T
    J Hematol Oncol; 2016 Mar; 9():20. PubMed ID: 26957312
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal miR‑663b exposed to TGF‑β1 promotes cervical cancer metastasis and epithelial‑mesenchymal transition by targeting MGAT3.
    You X; Wang Y; Meng J; Han S; Liu L; Sun Y; Zhang J; Sun S; Li X; Sun W; Dong Y; Zhang Y
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649791
    [TBL] [Abstract][Full Text] [Related]  

  • 34. HS-173, a novel PI3K inhibitor suppresses EMT and metastasis in pancreatic cancer.
    Rumman M; Jung KH; Fang Z; Yan HH; Son MK; Kim SJ; Kim J; Park JH; Lim JH; Hong S; Hong SS
    Oncotarget; 2016 Nov; 7(47):78029-78047. PubMed ID: 27793006
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Gambogic acid suppresses cancer invasion and migration by inhibiting TGFβ1-induced epithelial-to-mesenchymal transition.
    Zhao K; Zhang S; Song X; Yao Y; Zhou Y; You Q; Guo Q; Lu N
    Oncotarget; 2017 Apr; 8(16):27120-27136. PubMed ID: 28404892
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Triacetyl resveratrol upregulates miRNA‑200 and suppresses the Shh pathway in pancreatic cancer: A potential therapeutic agent.
    Fu J; Shrivastava A; Shrivastava SK; Srivastava RK; Shankar S
    Int J Oncol; 2019 Apr; 54(4):1306-1316. PubMed ID: 30720134
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Curcumin reverses the epithelial-mesenchymal transition of pancreatic cancer cells by inhibiting the Hedgehog signaling pathway.
    Sun XD; Liu XE; Huang DS
    Oncol Rep; 2013 Jun; 29(6):2401-7. PubMed ID: 23563640
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ovalitenone Inhibits the Migration of Lung Cancer Cells via the Suppression of AKT/mTOR and Epithelial-to-Mesenchymal Transition.
    Sanookpan K; Nonpanya N; Sritularak B; Chanvorachote P
    Molecules; 2021 Jan; 26(3):. PubMed ID: 33530617
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The effect of JDP2 and ATF2 on the epithelial-mesenchymal transition of human pancreatic cancer cell lines.
    Xu Y; Liu Z; Guo K
    Pathol Oncol Res; 2012 Jul; 18(3):571-7. PubMed ID: 22109562
    [TBL] [Abstract][Full Text] [Related]  

  • 40. TGF-β1/Smad signaling pathway regulates epithelial-to-mesenchymal transition in esophageal squamous cell carcinoma: in vitro and clinical analyses of cell lines and nomadic Kazakh patients from northwest Xinjiang, China.
    Pang L; Li Q; Wei C; Zou H; Li S; Cao W; He J; Zhou Y; Ju X; Lan J; Wei Y; Wang C; Zhao W; Hu J; Jia W; Qi Y; Liu F; Jiang J; Li L; Zhao J; Liang W; Xie J; Li F
    PLoS One; 2014; 9(12):e112300. PubMed ID: 25464508
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.